相关实验视频
Updated: Jun 28, 2025

08:36
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
1.1K
使用deucravacitinib抑制TYK2可以改善侵蚀性口腔平
Kim Natalie Stolte1,2, Alberto Mesas-Fernández2, Katharina Meier3
1Department of Periodontology, Oral Medicine and Oral Surgery, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
Experimental dermatology
|April 17, 2024
概括
德乌克拉维西替尼 (deucravacitinib) 在治疗口腔平坦 (OLP),一种困难的T细胞疾病方面表现有前途. 初步发现表明,这种选择性TYK-2抑制剂可能为OLP患者提供有益的治疗选择.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 侵蚀性口腔平 (OLP) 是一种由T细胞驱动的慢性疾病,治疗选择有限,对生活质量有重大影响.
- 目前的治疗方法,包括皮质类固醇,只能提供部分疗效,并且缺乏针对OLP的特定FDA/EMA批准.
- 干扰素- (IFN-ɣ) 被确定为OLP病变发生的关键细胞因子,突出其信号通路作为治疗点.
研究的目的:
- 评估选择性TYK-2抑制剂deucravacitinib在治疗侵蚀性口腔平患者中的潜在疗效.
- 探索针对IL-12/IFN-ɣ轴在OLP管理中的治疗作用.
主要方法:
- 一系列病例涉及三名被诊断患有口腔平坦的患者.
- 每天服用6毫克的德乌克拉维西提尼布.
- 对治疗反应和患者结果的临床观察.
主要成果:
- 德乌克拉维西替尼在所有三名接受口服OLP治疗的患者中都表现出有益的影响.
- 由deucravacitinib进行的选择性TYK-2抑制似乎调节了涉及OLP的致病途径.
结论:
- 德乌克拉维西提尼布代表了侵蚀性口腔平坦的潜在新型治疗候选者.
- 用选择性TYK-2抑制剂向IL-12/IFN-ɣ通路需要对OLP治疗进行进一步的研究.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K

